While hormone receptor-positive patients have more choices of treatment such as aromatase inhibitors and selective estrogen receptor modulators, ER-negative BC patients have fewer options, and the primary treatments are surgery and chemotherapies [4]. The gene discussed is ESR1; the disease is breast cancer.